CC
AGN

Columbia Capital’s Allergan Inc AGN Stock Holding History

Columbia Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.01M Buy
+4,745
New +$944K 1.1% 26

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Columbia Capital's AGN Position: Q4 2014 in Review

Columbia Capital opened a new position in Allergan Inc (AGN) in Q4 2014: 4,745 shares worth $1.01M. The stake represents 1.1% of the portfolio and ranks #26 among its holdings.

819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Columbia Capital held 4,745 shares of Allergan Inc worth $1.01M as of Q4 2014.
  • Allergan Inc was a new Columbia Capital position in Q4 2014.
  • Allergan Inc made up 1.1% of Columbia Capital's portfolio in Q4 2014, its #26 holding.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.